132 related articles for article (PubMed ID: 12653561)
41. Co-expression with BCR induces activation of the FES tyrosine kinase and phosphorylation of specific N-terminal BCR tyrosine residues.
Li J; Smithgall TE
J Biol Chem; 1996 Dec; 271(51):32930-6. PubMed ID: 8955135
[TBL] [Abstract][Full Text] [Related]
42. Reciprocal regulation of Hck activity by phosphorylation of Tyr(527) and Tyr(416). Effect of introducing a high affinity intramolecular SH2 ligand.
Porter M; Schindler T; Kuriyan J; Miller WT
J Biol Chem; 2000 Jan; 275(4):2721-6. PubMed ID: 10644735
[TBL] [Abstract][Full Text] [Related]
43. Intramolecular regulatory interactions in the Src family kinase Hck probed by mutagenesis of a conserved tryptophan residue.
LaFevre-Bernt M; Sicheri F; Pico A; Porter M; Kuriyan J; Miller WT
J Biol Chem; 1998 Nov; 273(48):32129-34. PubMed ID: 9822689
[TBL] [Abstract][Full Text] [Related]
44. Effect of the mutation of tyrosine 713 in p93c-fes on its catalytic activity and ability to promote myeloid differentiation in K562 cells.
Fang F; Ahmad S; Lei J; Klecker RW; Trepel JB; Smithgall TE; Glazer RI
Biochemistry; 1993 Jul; 32(27):6995-7001. PubMed ID: 8334128
[TBL] [Abstract][Full Text] [Related]
45. The lethality of p60v-src in Saccharomyces cerevisiae and the activation of p34CDC28 kinase are dependent on the integrity of the SH2 domain.
Boschelli F; Uptain SM; Lightbody JJ
J Cell Sci; 1993 Jun; 105 ( Pt 2)():519-28. PubMed ID: 7691844
[TBL] [Abstract][Full Text] [Related]
46. The nonreceptor protein-tyrosine kinase c-Fes is involved in fibroblast growth factor-2-induced chemotaxis of murine brain capillary endothelial cells.
Kanda S; Lerner EC; Tsuda S; Shono T; Kanetake H; Smithgall TE
J Biol Chem; 2000 Apr; 275(14):10105-11. PubMed ID: 10744691
[TBL] [Abstract][Full Text] [Related]
47. NMR assignment of the SH2 domain from the human feline sarcoma oncogene FES.
Scott A; Pantoja-Uceda D; Koshiba S; Inoue M; Kigawa T; Terada T; Shirouzu M; Tanaka A; Sugano S; Yokoyama S; Güntert P
J Biomol NMR; 2004 Dec; 30(4):463-4. PubMed ID: 15630569
[No Abstract] [Full Text] [Related]
48. Identification of amino acid residues required for a specific interaction between Src-tyrosine kinase and proline-rich region of phosphatidylinositol-3' kinase.
Mak P; He Z; Kurosaki T
FEBS Lett; 1996 Nov; 397(2-3):183-5. PubMed ID: 8955343
[TBL] [Abstract][Full Text] [Related]
49. Disruption of coiled-coil domains in Fer protein-tyrosine kinase abolishes trimerization but not kinase activation.
Craig AW; Zirngibl R; Greer P
J Biol Chem; 1999 Jul; 274(28):19934-42. PubMed ID: 10391941
[TBL] [Abstract][Full Text] [Related]
50. Interleukin-4 induces association of the c-fes proto-oncogene product with phosphatidylinositol-3 kinase.
Izuhara K; Feldman RA; Greer P; Harada N
Blood; 1996 Nov; 88(10):3910-8. PubMed ID: 8916957
[TBL] [Abstract][Full Text] [Related]
51. Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1.
Kim J; Feldman RA
Mol Cell Biol; 2002 Mar; 22(6):1903-18. PubMed ID: 11865067
[TBL] [Abstract][Full Text] [Related]
52. SH2 domains: modulators of nonreceptor tyrosine kinase activity.
Filippakopoulos P; Müller S; Knapp S
Curr Opin Struct Biol; 2009 Dec; 19(6):643-9. PubMed ID: 19926274
[TBL] [Abstract][Full Text] [Related]
53. Solution structure of the Src homology 2 domain from the human feline sarcoma oncogene Fes.
Scott A; Pantoja-Uceda D; Koshiba S; Inoue M; Kigawa T; Terada T; Shirouzu M; Tanaka A; Sugano S; Yokoyama S; Güntert P
J Biomol NMR; 2005 Apr; 31(4):357-61. PubMed ID: 15929003
[No Abstract] [Full Text] [Related]
54. FES/FER kinase signaling in hematopoietic cells and leukemias.
Craig AW
Front Biosci (Landmark Ed); 2012 Jan; 17(3):861-75. PubMed ID: 22201778
[TBL] [Abstract][Full Text] [Related]
55. Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation.
Filippakopoulos P; Kofler M; Hantschel O; Gish GD; Grebien F; Salah E; Neudecker P; Kay LE; Turk BE; Superti-Furga G; Pawson T; Knapp S
Cell; 2008 Sep; 134(5):793-803. PubMed ID: 18775312
[TBL] [Abstract][Full Text] [Related]
56. N-terminal sequences direct the autophosphorylation states of the FER tyrosine kinases in vivo.
Orlovsky K; Ben-Dor I; Priel-Halachmi S; Malovany H; Nir U
Biochemistry; 2000 Sep; 39(36):11084-91. PubMed ID: 10998246
[TBL] [Abstract][Full Text] [Related]
57. Structure and regulation of the c-Fes protein-tyrosine kinase.
Hellwig S; Smithgall TE
Front Biosci (Landmark Ed); 2011 Jun; 16(8):3146-55. PubMed ID: 21622225
[TBL] [Abstract][Full Text] [Related]
58. Characterization and phylogenetic analysis of a cDNA encoding the Fes/FER related, non-receptor protein-tyrosine kinase in the marine sponge sycon raphanus.
Cetkovic H; Müller IM; Müller WE; Gamulin V
Gene; 1998 Aug; 216(1):77-84. PubMed ID: 9714748
[TBL] [Abstract][Full Text] [Related]
59. The Fes protein-tyrosine kinase phosphorylates a subset of macrophage proteins that are involved in cell adhesion and cell-cell signaling.
Jücker M; McKenna K; da Silva AJ; Rudd CE; Feldman RA
J Biol Chem; 1997 Jan; 272(4):2104-9. PubMed ID: 8999909
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of endothelial cell chemotaxis toward FGF-2 by gefitinib associates with downregulation of Fes activity.
Kanda S; Naba A; Miyata Y
Int J Oncol; 2009 Dec; 35(6):1305-12. PubMed ID: 19885553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
